Renaissance Technologies’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
1,812,251
-42,850
| -2% | -$35.6K | ﹤0.01% | 2287 |
|
|
2025
Q1 | $1.25M | Buy |
1,855,101
+297,469
| +19% | +$200K | ﹤0.01% | 2267 |
|
|
2024
Q4 | $1.47M | Buy |
1,557,632
+247,562
| +19% | +$234K | ﹤0.01% | 2260 |
|
|
2024
Q3 | $1.99M | Sell |
1,310,070
-240,840
| -16% | -$366K | ﹤0.01% | 2027 |
|
|
2024
Q2 | $1.85M | Buy |
1,550,910
+164,540
| +12% | +$196K | ﹤0.01% | 1925 |
|
|
2024
Q1 | $2.5M | Buy |
1,386,370
+102,100
| +8% | +$184K | ﹤0.01% | 1884 |
|
|
2023
Q4 | $1.13M | Buy |
1,284,270
+41,900
| +3% | +$36.9K | ﹤0.01% | 2327 |
|
|
2023
Q3 | $915K | Buy |
1,242,370
+168,300
| +16% | +$124K | ﹤0.01% | 2369 |
|
|
2023
Q2 | $1.35M | Buy |
1,074,070
+138,000
| +15% | +$174K | ﹤0.01% | 2264 |
|
|
2023
Q1 | $679K | Buy |
936,070
+91,300
| +11% | +$66.2K | ﹤0.01% | 2706 |
|
|
2022
Q4 | $446K | Sell |
844,770
-250,940
| -23% | -$132K | ﹤0.01% | 3012 |
|
|
2022
Q3 | $913K | Sell |
1,095,710
-894,285
| -45% | -$745K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $2.17M | Sell |
1,989,995
-110,497
| -5% | -$120K | ﹤0.01% | 2125 |
|
|
2022
Q1 | $2.63M | Buy |
2,100,492
+930,152
| +79% | +$1.16M | ﹤0.01% | 2019 |
|
|
2021
Q4 | $1.87M | Buy |
+1,170,340
| New | +$1.87M | ﹤0.01% | 2193 |
|
|
2021
Q2 | – | Sell |
-3,304,140
| Closed | -$6.97M | – | 3440 |
|
|
2021
Q1 | $6.97M | Buy |
3,304,140
+2,811,340
| +570% | +$5.93M | 0.01% | 1445 |
|
|
2020
Q4 | $468K | Buy |
492,800
+418,320
| +562% | +$397K | ﹤0.01% | 2846 |
|
|
2020
Q3 | $180K | Buy |
+74,480
| New | +$180K | ﹤0.01% | 3131 |
|
|
2020
Q1 | – | Sell |
-26,200
| Closed | -$41K | – | 3431 |
|
|
2019
Q4 | $41K | Buy |
+26,200
| New | +$41K | ﹤0.01% | 3407 |
|
|
2018
Q1 | – | Sell |
-902
| Closed | -$3K | – | 3359 |
|
|
2017
Q4 | $3K | Sell |
902
-27,057
| -97% | -$90K | ﹤0.01% | 3303 |
|
|
2017
Q3 | $178K | Sell |
27,959
-2,167
| -7% | -$13.8K | ﹤0.01% | 3021 |
|
|
2017
Q2 | $181K | Buy |
30,126
+18,633
| +162% | +$112K | ﹤0.01% | 3012 |
|
|
2017
Q1 | $105K | Buy |
11,493
+3,925
| +52% | +$35.9K | ﹤0.01% | 3078 |
|
|
2016
Q4 | $128K | Buy |
7,568
+4,125
| +120% | +$69.8K | ﹤0.01% | 3064 |
|
|
2016
Q3 | $87K | Buy |
3,443
+1,486
| +76% | +$37.5K | ﹤0.01% | 3194 |
|
|
2016
Q2 | $99K | Buy |
1,957
+443
| +29% | +$22.4K | ﹤0.01% | 3161 |
|
|
2016
Q1 | $94K | Buy |
1,514
+904
| +148% | +$56.1K | ﹤0.01% | 3222 |
|
|
2015
Q4 | $35K | Buy |
+610
| New | +$35K | ﹤0.01% | 3208 |
|